Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
Clinical trials are essential for advancing medicine. Thanks to them, today we now have safer, more effective, and increasingly personalized treatments. However, for many people, participating in a clinical trial naturally raises questions: What does participation involve? How does the process unfold? What kind of follow‑up is provided? At RESILIENCE,
Early detection of cardiac damage is one of the most effective tools to prevent cardiovascular complications, improve prognosis, and preserve quality of life. Identifying alterations in the heart before symptoms appear allows for early intervention, treatment adjustments, and protection of cardiovascular health in both the short and long term. This
December arrives each year with the perfect blend of excitement, celebrations, and long-awaited reunions. These are days to share, enjoy, and create memories with those we love most. At the same time, it is also a season when our habits tend to change: richer meals, more alcohol than usual, less
Autumn brings shorter days, cooler temperatures that invite for warm clothing, and a routine that sometimes sets the pace again. This season often fosters a sense of tranquility; however, it may also be accompanied by increased fatigue, emotional fluctuations, or elevated stress levels. For those going through an oncological process,
Cardiovascular research has just taken a huge step forward. The REBOOT clinical trial, led by the Spanish National Center for Cardiovascular Research (CNIC) in collaboration with the Mario Negri Institute in Milan, has shown that a medical practice in place for more than 40 years may no longer be necessary
Cancer, along with cardiovascular diseases, is among the leading causes of mortality worldwide. In Spain, it ranks first in both incidence and number of deaths. However, it is estimated that only between 5% and 10% of cases are genetic or hereditary. The remaining cases are associated with environmental factors and
